Three Peaks Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$4.23M Sell
29,757
-9,905
-25% -$1.46M 1.41% 26
2021
Q2
$6.19M Buy
39,662
+650
+2% +$105K 1.91% 6
2021
Q1
$6.06M Sell
39,012
-699
-2% -$108K 1.91% 4
2020
Q4
$5.94M Buy
39,711
+22,065
+125% +$3.12M 1.9% 2
2020
Q3
$2.33M Sell
17,646
-1,841
-9% -$240K 0.82% 55
2020
Q2
$2.26M Sell
19,487
-7,380
-27% -$850K 0.83% 58
2020
Q1
$2.64M Sell
26,867
-527
-2% -$69.1K 1.05% 49
2019
Q4
$3.98M Buy
27,394
+383
+1% +$52.9K 1.05% 46
2019
Q3
$3.6M Buy
27,011
+2,042
+8% +$264K 1.03% 48
2019
Q2
$2.85M Buy
24,969
+2,684
+12% +$314K 0.83% 61
2019
Q1
$2.76M Buy
+22,285
New +$2.53M 0.81% 68

Other funds holding ZBH

Three Peaks Capital Management's ZBH Position: Q3 2021 in Review

Three Peaks Capital Management reduced its Zimmer Biomet (ZBH) stake by 25% in Q3 2021, selling an estimated $1.46M and leaving 29,757 shares worth $4.23M. The position accounts for 1.41% of the portfolio, ranked #26.

Three Peaks Capital Management first reported a position in ZBH in Q1 2019 and has held it in 11 quarters since. The position peaked at $6.19M in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

  • Three Peaks Capital Management held 29,757 shares of Zimmer Biomet worth $4.23M as of Q3 2021.
  • Three Peaks Capital Management sold 9,905 Zimmer Biomet shares in Q3 2021, an estimated $1.46M.
  • Zimmer Biomet made up 1.41% of Three Peaks Capital Management's portfolio in Q3 2021, its #26 holding.
  • Three Peaks Capital Management first reported a position in Zimmer Biomet in Q1 2019 and has held it in 11 quarters since.
  • Three Peaks Capital Management's Zimmer Biomet position peaked at $6.19M in Q2 2021.
  • 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Three Peaks Capital Management's 13F filing for Q3 2021, filed 12 Oct 2021.